GLP1R and obesity disorder: Despite the well-known connection between obesity and chronic subclinical inflammation, we did not observe a significant reduction in the studied inflammatory markers (ferritin, IL-6, TNF- α resistin, PAI-1) following the treatment with submaximal GLP-1 RA.